Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
Rohn
A
A
Kessler
H H
HH
Valentin
T
T
Linkesch
W
W
Neumeister
P
P
D000998:Antiviral Agents / Q000627:therapeutic use*; D001782:Blood Donors; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000517:prevention & control* / Q000635:transmission; D008875:Middle Aged; D053139:Oseltamivir / Q000627:therapeutic use*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*
D000998:Antiviral Agents; D053139:Oseltamivir